Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives

Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives

Heart failure (HF) is the leading cause of death worldwide. The most effective HF treatment is heart transplantation, the use of which is restricted by the limited supply of donor hearts. The human pluripotent stem cell (hPSC), including human embryonic stem cell (hESC) and the induced pluripotent s...

Full description

Bibliographic Details
Main Authors: Junjun Li, Li Liu, Jingbo Zhang, Xiang Qu, Takuji Kawamura, Shigeru Miyagawa, Yoshiki Sawa
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Bioengineering
Subjects:
heart failure
human induced pluripotent stem cells
cardiac regeneration
tissue engineering
cardiomyocytes
Online Access:https://www.mdpi.com/2306-5354/9/11/605

Similar Items

Similar Items